Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Abstract Familial gastrointestinal stromal tumors (GIST) are rare. We present a kindred with multiple family members affected with multifocal GIST who underwent whole genome sequencing of the germline and tumor. Affected individuals with GIST harbored a germline variant found within exon 13 of the K...
Main Authors: | K. M. Ingley, M. Zatzman, A. M. Fontebasso, W. Lo, V. Subasri, A. Goldenberg, Y. Li, S. Davidson, N. Kanwar, L. Waldman, L. Brunga, Y. Babichev, E. G. Demicco, A. Gupta, M. Szybowska, S. Thipphavong, D. Malkin, A. Villani, A. Shlien, R. A. Gladdy, R. H. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-024-00405-z |
Similar Items
-
Update on management of GIST and postsurgical use of imatinib
by: E Pennacchioli, et al.
Published: (2010-08-01) -
Imatinib and gastrointestinal stromal tumor (GIST): a selective targeted therapy Imatinib y tumor del estroma gastrointestinal (GIST): un tratamiento selectivo frente a una diana molecular
by: A. Fernández, et al.
Published: (2004-10-01) -
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
by: Richard Quek, et al.
Published: (2010-02-01) -
Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.
by: Hiroyuki Sako, et al.
Published: (2014-01-01) -
Tumor volume as an alternative response measurement for imatinib treated GIST patients.
by: Gaia Schiavon, et al.
Published: (2012-01-01)